class,text
3,Early diagnosis and treatment did not prevent ASD as an outcome of IS .
3,Early diagnosis and treatment did not prevent ASD as a result of AR.
3,Early diagnosis and treatment did not prevent ASD as a result of AR.
3,Early diagnosis and treatment did not prevent ASD as a result of AR.
3,Early diagnosis and treatment did not prevent ASD as a result of AR.
4,Comparing individuals with SIS to those without shoulder pathology may provide information on the effects of TSM specifically in those with SIS .
4,Comparison of people with SIS with those with no shoulder disease may provide information on the effects of STD specifically in people with SIS.
4,Comparison of people with SIS with those with no shoulder disease may provide information on the effects of STD specifically in people with SIS.
4,Comparison of people with SIS with those with no shoulder disease may provide information on the effects of STD specifically in people with SIS.
4,Comparison of people with SIS with those with no shoulder disease may provide information on the effects of STD specifically in people with SIS.
2,The accumulated expelled volumes for an hour were in favor of the ASCD group .
2,The evicted volumes accumulated for one hour were in favour of the ASCD group.
2,The evicted volumes accumulated for one hour were in favour of the ASCD group.
2,The evicted volumes accumulated for one hour were in favour of the ASCD group.
2,The evicted volumes accumulated for one hour were in favour of the ASCD group.
1,Five sham acupoints are used in the control group .
1,Five acupoints are used in the control group.
1,Five acupoints are used in the control group.
1,Five acupoints are used in the control group.
1,Five acupoints are used in the control group.
2,There were relevant differences between patients and healthy control subjects in postural sway and DTI diffusion-tensor imaging parameters ( P < .05 ) .
2,There were relevant differences between patients and healthy control subjects in ICT diffusion-tensive imaging parameters and postural right-of-way ( P < 0.05 ).
2,There were relevant differences between patients and healthy control subjects in ICT diffusion-tensive imaging parameters and postural right-of-way ( P < 0.05 ).
2,There were relevant differences between patients and healthy control subjects in ICT diffusion-tensive imaging parameters and postural right-of-way ( P < 0.05 ).
2,There were relevant differences between patients and healthy control subjects in ICT diffusion-tensive imaging parameters and postural right-of-way ( P < 0.05 ).
0,"Recurrent signs and symptoms are common despite treatment with a gluten-free diet ( GFD ) , yet no approved or proven nondietary treatment is available ."
0,"Recurrent signs and symptoms are common despite treatment with gluten-free diet (GFD), but no approved or proven non-food treatment is available."
0,"Recurrent signs and symptoms are common despite treatment with gluten-free diet (GFD), but no approved or proven non-food treatment is available."
0,"Recurrent signs and symptoms are common despite treatment with gluten-free diet (GFD), but no approved or proven non-food treatment is available."
0,"Recurrent signs and symptoms are common despite treatment with gluten-free diet (GFD), but no approved or proven non-food treatment is available."
0,"Opioid pharmacotherapy is now the leading treatment for chronic pain , a problem that affects nearly one third of the U.S. population ."
0,"Opioid pharmacotherapy is now the main treatment for chronic pain, a problem that affects nearly a third of the American population."
0,"Opioid pharmacotherapy is now the main treatment for chronic pain, a problem that affects nearly a third of the American population."
2,"The frequencies of recurrent pleural effusions requiring reintervention were 5.88 % ( 3/51 ) , 4.35 % ( 2/46 ) and 5.26 % ( 3/57 ) , respectively , which had no significant differences between three groups ( P = 1.000 ) ."
2,"Recurrent pleural effusion frequencies requiring re-intervention were 5.88% ( 3/51), 4.35% ( 2/46) and 5.26% ( 3/57), respectively, which did not differ significantly between three groups ( P = 1,000)."
2,"Recurrent pleural effusion frequencies requiring re-intervention were 5.88% ( 3/51), 4.35% ( 2/46) and 5.26% ( 3/57), respectively, which did not differ significantly between three groups ( P = 1,000)."
2,"Recurrent pleural effusion frequencies requiring re-intervention were 5.88% ( 3/51), 4.35% ( 2/46) and 5.26% ( 3/57), respectively, which did not differ significantly between three groups ( P = 1,000)."
2,"Recurrent pleural effusion frequencies requiring re-intervention were 5.88% ( 3/51), 4.35% ( 2/46) and 5.26% ( 3/57), respectively, which did not differ significantly between three groups ( P = 1,000)."
0,"Opioid pharmacotherapy is now the main treatment for chronic pain, a problem that affects nearly a third of the American population."
0,"Opioid pharmacotherapy is now the main treatment for chronic pain, a problem that affects nearly a third of the American population."
3,The pharmacogenetic findings also implicate the kainate receptor in the mechanism of topiramate 's effects on heavy drinking .
3,Pharmacogenetic results also involve the kainate receptor in the mechanism of the effects of topiramate on heavy alcohol.
3,Pharmacogenetic results also involve the kainate receptor in the mechanism of the effects of topiramate on heavy alcohol.
3,Pharmacogenetic results also involve the kainate receptor in the mechanism of the effects of topiramate on heavy alcohol.
3,Pharmacogenetic results also involve the kainate receptor in the mechanism of the effects of topiramate on heavy alcohol.
4,"Additionally , it was investigated if cheek cell FA composition correlates with the FA composition of plasma , red blood cells ( RBC ) and peripheral blood mononuclear cells ( PBMC ) before and during both interventions ."
4,"In addition, it has been investigated whether the composition of the cheeks' FAs correlates with the composition of plasma, red blood cells (RBCs) and peripheral blood mononuclear cells (PBMCs) prior to and during both procedures."
4,"In addition, it has been investigated whether the composition of the cheeks' FAs correlates with the composition of plasma, red blood cells (RBCs) and peripheral blood mononuclear cells (PBMCs) prior to and during both procedures."
4,"In addition, it has been investigated whether the composition of the cheeks' FAs correlates with the composition of plasma, red blood cells (RBCs) and peripheral blood mononuclear cells (PBMCs) prior to and during both procedures."
4,"In addition, it has been investigated whether the composition of the cheeks' FAs correlates with the composition of plasma, red blood cells (RBCs) and peripheral blood mononuclear cells (PBMCs) prior to and during both procedures."
0,We estimate the effect size of hypoglycemia risk reduction on closed-loop control ( CLC ) versus open-loop ( OL ) sensor-augmented insulin pump therapy in supervised outpatient setting .
0,We estimate the size of the effect of reducing the risk of hypoglycaemia on closed-loop control (CLC) compared to the sensor-enhanced open-loop insulin pump (LO) treatment in supervised external consultations.
0,We estimate the size of the effect of reducing the risk of hypoglycaemia on closed-loop control (CLC) compared to the sensor-enhanced open-loop insulin pump (LO) treatment in supervised external consultations.
0,We estimate the size of the effect of reducing the risk of hypoglycaemia on closed-loop control (CLC) compared to the sensor-enhanced open-loop insulin pump (LO) treatment in supervised external consultations.
0,We estimate the size of the effect of reducing the risk of hypoglycaemia on closed-loop control (CLC) compared to the sensor-enhanced open-loop insulin pump (LO) treatment in supervised external consultations.
2,After 6 months of therapy the level of microalbuminuria decreased significantly in the study group compared with the control group .
2,"After 6 months of treatment, the microalbuminuria level decreased significantly in the study group compared to the control group."
2,"After 6 months of treatment, the microalbuminuria level decreased significantly in the study group compared to the control group."
2,"After 6 months of treatment, the microalbuminuria level decreased significantly in the study group compared to the control group."
2,"After 6 months of treatment, the microalbuminuria level decreased significantly in the study group compared to the control group."
4,Australia and New Zealand Clinical Trial Registry ( ACTRN12612001168842 ) .
4,Register of Clinical Trials of Australia and New Zealand ( ACTRN1261/2001168842 ).
4,Register of Clinical Trials of Australia and New Zealand ( ACTRN1261/2001168842 ).
3,"Furthermore , optimally programmed AVD reduces BNP and improves exercise tolerance and functional class ."
3,"In addition, the optimally programmed AVD reduces the BNP and improves exercise tolerance and functional class."
3,"In addition, the optimally programmed AVD reduces the BNP and improves exercise tolerance and functional class."
3,"In addition, the optimally programmed AVD reduces the BNP and improves exercise tolerance and functional class."
3,"In addition, the optimally programmed AVD reduces the BNP and improves exercise tolerance and functional class."
4,So far there is no evidence whether oral beta-blockers may reduce myocardial injury after coronary artery bypass grafting .
4,"So far, there is no evidence that oral beta blockers can reduce myocardial lesions after the coronary artery bypass transplant."
4,"So far, there is no evidence that oral beta blockers can reduce myocardial lesions after the coronary artery bypass transplant."
4,"So far, there is no evidence that oral beta blockers can reduce myocardial lesions after the coronary artery bypass transplant."
4,"So far, there is no evidence that oral beta blockers can reduce myocardial lesions after the coronary artery bypass transplant."
4,Register of Clinical Trials of Australia and New Zealand ( ACTRN1261/2001168842 ).
0,The aim of the study was to assess the effects of three different testosterone formulations on body weight and composition and metabolic and bone parameters .
0,The objective of the study was to evaluate the effects of three different testosterone formulations on body weight and composition as well as metabolic and bone parameters.
0,The objective of the study was to evaluate the effects of three different testosterone formulations on body weight and composition as well as metabolic and bone parameters.
0,The objective of the study was to evaluate the effects of three different testosterone formulations on body weight and composition as well as metabolic and bone parameters.
0,The objective of the study was to evaluate the effects of three different testosterone formulations on body weight and composition as well as metabolic and bone parameters.
2,Five shoulders in the DCR+RCR group and 6 in the isolated RCR group were excluded from analysis due to loss of follow-up .
2,Five shoulders in the DCR+RCR group and six in the isolated RCR group were excluded from the analysis due to loss of follow-up.
2,Five shoulders in the DCR+RCR group and six in the isolated RCR group were excluded from the analysis due to loss of follow-up.
4,DNA methylation has been linked to many important biological phenomena .
4,DNA methylation has been linked to many important biological phenomena.
4,DNA methylation has been linked to many important biological phenomena.
4,DNA methylation has been linked to many important biological phenomena.
4,DNA methylation has been linked to many important biological phenomena.
2,Five shoulders in the DCR+RCR group and six in the isolated RCR group were excluded from the analysis due to loss of follow-up.
2,Five shoulders in the DCR+RCR group and six in the isolated RCR group were excluded from the analysis due to loss of follow-up.
1,All participants will undergo standard long down regulation protocol using human menopausal gonadotropin 300IU/day .
1,All participants will undergo a standard long-term control protocol using human menopause gonadotrophin 300UI/day.
1,All participants will undergo a standard long-term control protocol using human menopause gonadotrophin 300UI/day.
1,All participants will undergo a standard long-term control protocol using human menopause gonadotrophin 300UI/day.
1,All participants will undergo a standard long-term control protocol using human menopause gonadotrophin 300UI/day.
4,Blood collection through intravenous lines frequently causes spurious hemolysis .
4,Intravenous blood collection frequently causes false haemolysis.
4,Intravenous blood collection frequently causes false haemolysis.
4,Intravenous blood collection frequently causes false haemolysis.
4,Intravenous blood collection frequently causes false haemolysis.
3,"Moreover , it will assess the risks associated with this procedure ."
3,"In addition, it will assess the risks associated with this procedure."
3,"In addition, it will assess the risks associated with this procedure."
3,"In addition, it will assess the risks associated with this procedure."
3,"In addition, it will assess the risks associated with this procedure."
3,Meropenem at 1000mg over 30 minutes achieved a similar % TMIC to meropenem at 500mg given over 3 hours .
3,Meropenem at 1000mg over 30 minutes obtained a similar percentage of meropenem TMIC at 500mg over 3 hours.
3,Meropenem at 1000mg over 30 minutes obtained a similar percentage of meropenem TMIC at 500mg over 3 hours.
3,Meropenem at 1000mg over 30 minutes obtained a similar percentage of meropenem TMIC at 500mg over 3 hours.
3,Meropenem at 1000mg over 30 minutes obtained a similar percentage of meropenem TMIC at 500mg over 3 hours.
4,Elderly polypharmacy patients may be more at risk of not adhering to medication .
4,Elderly patients with polypharmacy may be at greater risk of not joining medicines.
4,Elderly patients with polypharmacy may be at greater risk of not joining medicines.
4,Elderly patients with polypharmacy may be at greater risk of not joining medicines.
4,Elderly patients with polypharmacy may be at greater risk of not joining medicines.
0,To investigate effects of intra-abdominal pressure in pregnancy on the development of spinal blockade and incidence of hypotension during cesarean section .
0,Study the effects of intra-abdominal pressure during pregnancy on the development of spinal blockage and the incidence of hypotension during the cesarean section.
0,Study the effects of intra-abdominal pressure during pregnancy on the development of spinal blockage and the incidence of hypotension during the cesarean section.
0,Study the effects of intra-abdominal pressure during pregnancy on the development of spinal blockage and the incidence of hypotension during the cesarean section.
0,Study the effects of intra-abdominal pressure during pregnancy on the development of spinal blockage and the incidence of hypotension during the cesarean section.
3,"The time of the pain beginning was 8.31 4.58 min in the treatment group and 7.10 3.54 min in the placebo group , which was not significantly different ( P = 0.266 ) ."
3,"The onset of pain was 8.31 4.58 min in the treated group and 7.10 3.54 min in the placebo group, which was not significantly different (P = 0.266)."
3,"The onset of pain was 8.31 4.58 min in the treated group and 7.10 3.54 min in the placebo group, which was not significantly different (P = 0.266)."
4,We investigated the impact of different group sizes on the outcome of resuscitation training .
4,We studied the impact of different group sizes on the outcome of resuscitation training.
4,We studied the impact of different group sizes on the outcome of resuscitation training.
4,We studied the impact of different group sizes on the outcome of resuscitation training.
4,We studied the impact of different group sizes on the outcome of resuscitation training.
3,"The onset of pain was 8.31 4.58 min in the treated group and 7.10 3.54 min in the placebo group, which was not significantly different (P = 0.266)."
3,"The onset of pain was 8.31 4.58 min in the treated group and 7.10 3.54 min in the placebo group, which was not significantly different (P = 0.266)."
0,"We sought to assess if the use of a solution of mepivacaine 2 % plus adrenaline with sodium bicarbonate 1.4 % results in less pain associated with local infiltration anesthesia preceding ambulatory phlebectomies , compared with standard preparation diluted with normal saline ."
0,"We examined whether the use of a mepivacaine solution 2% more adrenaline with sodium bicarbonate 1.4% results in less pain associated with local infiltration anaesthesia prior to ambulatory phlebectomies, compared to the standard preparation diluted with normal saline solution."
0,"We examined whether the use of a mepivacaine solution 2% more adrenaline with sodium bicarbonate 1.4% results in less pain associated with local infiltration anaesthesia prior to ambulatory phlebectomies, compared to the standard preparation diluted with normal saline solution."
0,"We examined whether the use of a mepivacaine solution 2% more adrenaline with sodium bicarbonate 1.4% results in less pain associated with local infiltration anaesthesia prior to ambulatory phlebectomies, compared to the standard preparation diluted with normal saline solution."
0,"We examined whether the use of a mepivacaine solution 2% more adrenaline with sodium bicarbonate 1.4% results in less pain associated with local infiltration anaesthesia prior to ambulatory phlebectomies, compared to the standard preparation diluted with normal saline solution."
4,"The objectives were to determine whether pulmonary rehabilitation increased physical activity as assessed by the International Physical Activity Questionnaire ( IPAQ ) , and improved quality of life and symptoms as assessed by the St George respiratory questionnaire for IPF ( SGRQ-I ) and the Borg dyspnea index ( BDI ) ."
4,"The objectives were to determine whether pulmonary rehabilitation increased physical activity as assessed by the International Physical Activity Questionnaire (IPAQ), and to improve the quality of life and symptoms as assessed by the St. George Respiratory Questionnaire for IPF (IGQ-I) and the Borg Dyspnea Index (BDI)."
4,"The objectives were to determine whether pulmonary rehabilitation increased physical activity as assessed by the International Physical Activity Questionnaire (IPAQ), and to improve the quality of life and symptoms as assessed by the St. George Respiratory Questionnaire for IPF (IGQ-I) and the Borg Dyspnea Index (BDI)."
4,"The objectives were to determine whether pulmonary rehabilitation increased physical activity as assessed by the International Physical Activity Questionnaire (IPAQ), and to improve the quality of life and symptoms as assessed by the St. George Respiratory Questionnaire for IPF (IGQ-I) and the Borg Dyspnea Index (BDI)."
4,"The objectives were to determine whether pulmonary rehabilitation increased physical activity as assessed by the International Physical Activity Questionnaire (IPAQ), and to improve the quality of life and symptoms as assessed by the St. George Respiratory Questionnaire for IPF (IGQ-I) and the Borg Dyspnea Index (BDI)."
0,"This study used an in-depth mixed-methods design to examine individual variation in ( 1 ) impact on self-reported goal engagement ( ie , motivation , self-efficacy , awareness , effort , achievement ) of access to a weight management app ( POWeR Tracker ) when provided alongside a Web-based weight management intervention ( POWeR ) and ( 2 ) usage and views of POWeR Tracker ."
0,"This study used an in-depth design of mixed methods to examine individual variations in ( 1 ) the impact on self-declared objective engagement (i.e. motivation, self-efficacy, awareness, effort, realization ) of access to a POWER Tracker application when provided in conjunction with a web-based weight management intervention ( POWER ) and ( 2 ) the use and views of POWER Tracker."
0,"This study used an in-depth design of mixed methods to examine individual variations in ( 1 ) the impact on self-declared objective engagement (i.e. motivation, self-efficacy, awareness, effort, realization ) of access to a POWER Tracker application when provided in conjunction with a web-based weight management intervention ( POWER ) and ( 2 ) the use and views of POWER Tracker."
0,"This study used an in-depth design of mixed methods to examine individual variations in ( 1 ) the impact on self-declared objective engagement (i.e. motivation, self-efficacy, awareness, effort, realization ) of access to a POWER Tracker application when provided in conjunction with a web-based weight management intervention ( POWER ) and ( 2 ) the use and views of POWER Tracker."
0,"This study used an in-depth design of mixed methods to examine individual variations in ( 1 ) the impact on self-declared objective engagement (i.e. motivation, self-efficacy, awareness, effort, realization ) of access to a POWER Tracker application when provided in conjunction with a web-based weight management intervention ( POWER ) and ( 2 ) the use and views of POWER Tracker."
3,These data demonstrate that the acarbose/metformin FDC is bioequivalent to the loose combination of these agents .
3,These data demonstrate that acarbose/metformin FDC is bioequivalent to the loose combination of these agents.
3,These data demonstrate that acarbose/metformin FDC is bioequivalent to the loose combination of these agents.
3,These data demonstrate that acarbose/metformin FDC is bioequivalent to the loose combination of these agents.
3,These data demonstrate that acarbose/metformin FDC is bioequivalent to the loose combination of these agents.
3,"Propofol and isoflurane exert similar adverse effects on RT , psychomotor coordination , and visual memory ."
3,"Propofol and isoflurane have similar adverse effects on RT, psychomotor coordination and visual memory."
3,"Propofol and isoflurane have similar adverse effects on RT, psychomotor coordination and visual memory."
3,Clinical benefit was lower in patients with de-novo Thr790Met and exon 20 insertion mutations .
3,The clinical benefit was lower in patients with de-novo Thr790Met and exon 20 insertion mutations.
3,The clinical benefit was lower in patients with de-novo Thr790Met and exon 20 insertion mutations.
3,The clinical benefit was lower in patients with de-novo Thr790Met and exon 20 insertion mutations.
3,The clinical benefit was lower in patients with de-novo Thr790Met and exon 20 insertion mutations.
3,"Propofol and isoflurane have similar adverse effects on RT, psychomotor coordination and visual memory."
3,"Propofol and isoflurane have similar adverse effects on RT, psychomotor coordination and visual memory."
3,"Trial design , protocol specification , training , and continuous supervision led to a high degree of treatment fidelity for the counseling interventions in this randomized clinical trial and will increase confidence in the interpretation of the trial findings ."
3,"The design of trials, protocol specification, training and ongoing monitoring have led to a high degree of treatment fidelity for counselling interventions in this randomized clinical trial and will increase confidence in the interpretation of trial results."
3,"The design of trials, protocol specification, training and ongoing monitoring have led to a high degree of treatment fidelity for counselling interventions in this randomized clinical trial and will increase confidence in the interpretation of trial results."
3,"The design of trials, protocol specification, training and ongoing monitoring have led to a high degree of treatment fidelity for counselling interventions in this randomized clinical trial and will increase confidence in the interpretation of trial results."
3,"The design of trials, protocol specification, training and ongoing monitoring have led to a high degree of treatment fidelity for counselling interventions in this randomized clinical trial and will increase confidence in the interpretation of trial results."
0,Study participants were randomly assigned to receive amantadine hydrochloride 100 mg twice daily versus equivalent placebo for 28 days .
0,Study participants were randomly given amantadine hydrochloride 100 mg twice daily compared to placebo equivalent for 28 days.
0,Study participants were randomly given amantadine hydrochloride 100 mg twice daily compared to placebo equivalent for 28 days.
0,Study participants were randomly given amantadine hydrochloride 100 mg twice daily compared to placebo equivalent for 28 days.
0,Study participants were randomly given amantadine hydrochloride 100 mg twice daily compared to placebo equivalent for 28 days.
0,The objective of this study was to explore the effects of hypotonic and isotonic oral mannitol on intestinal distention and fluorine-18 fluorodeoxyglucose ( ( 18 ) F-FDG ) intake in PET/computed tomography ( CT ) imaging .
0,The objective of this study was to explore the effects of hypotonic and isotonic oral mannitol on intestinal distention and absorption of fluoride-18 fluorodeoxyglucose ( ( (18 ) F-FDG ) in calculated tomography imaging ( CT).
0,The objective of this study was to explore the effects of hypotonic and isotonic oral mannitol on intestinal distention and absorption of fluoride-18 fluorodeoxyglucose ( ( (18 ) F-FDG ) in calculated tomography imaging ( CT).
0,The objective of this study was to explore the effects of hypotonic and isotonic oral mannitol on intestinal distention and absorption of fluoride-18 fluorodeoxyglucose ( ( (18 ) F-FDG ) in calculated tomography imaging ( CT).
0,The objective of this study was to explore the effects of hypotonic and isotonic oral mannitol on intestinal distention and absorption of fluoride-18 fluorodeoxyglucose ( ( (18 ) F-FDG ) in calculated tomography imaging ( CT).
4,"Dietary patterns that are considered healthy ( eg , the Dietary Approaches to Stop Hypertension diet and Mediterranean diet ) may be more successful in reducing typical cardiovascular disease risks compared to dietary patterns considered unhealthy ( eg , energy-dense diets such as the typical American diet ) ."
4,"Diets that are considered healthy (e.g. dietary approaches to stopping hypertension and the Mediterranean diet) can be more effective in reducing the risk of typical cardiovascular diseases than diets that are considered unhealthy (e.g., energy diets such as the typical American diet)."
4,"Diets that are considered healthy (e.g. dietary approaches to stopping hypertension and the Mediterranean diet) can be more effective in reducing the risk of typical cardiovascular diseases than diets that are considered unhealthy (e.g., energy diets such as the typical American diet)."
4,"Diets that are considered healthy (e.g. dietary approaches to stopping hypertension and the Mediterranean diet) can be more effective in reducing the risk of typical cardiovascular diseases than diets that are considered unhealthy (e.g., energy diets such as the typical American diet)."
4,"Diets that are considered healthy (e.g. dietary approaches to stopping hypertension and the Mediterranean diet) can be more effective in reducing the risk of typical cardiovascular diseases than diets that are considered unhealthy (e.g., energy diets such as the typical American diet)."
0,Sildenafil ( SIL ) and vardenafil ( VAR ) are approved for as-needed ( PRN ) dosing ; tadalafil ( TAD ) is approved for both PRN and once-a-day ( OaD ) dosing for ED .
0,Sildenafil ( SIL ) and vardenafil ( VAR ) are approved if necessary ( PRN ) ; tadalafil ( TAD ) is approved for both NRP and once daily ( OaD ) for ED.
0,Sildenafil ( SIL ) and vardenafil ( VAR ) are approved if necessary ( PRN ) ; tadalafil ( TAD ) is approved for both NRP and once daily ( OaD ) for ED.
0,Sildenafil ( SIL ) and vardenafil ( VAR ) are approved if necessary ( PRN ) ; tadalafil ( TAD ) is approved for both NRP and once daily ( OaD ) for ED.
0,Sildenafil ( SIL ) and vardenafil ( VAR ) are approved if necessary ( PRN ) ; tadalafil ( TAD ) is approved for both NRP and once daily ( OaD ) for ED.
1,"In addition , for all eye drop treatment groups , open-label ranibizumab was administered as needed ."
1,"In addition, for all eye drops treatment groups, open ranibizumab was administered as required."
1,"In addition, for all eye drops treatment groups, open ranibizumab was administered as required."
1,"In addition, for all eye drops treatment groups, open ranibizumab was administered as required."
1,"In addition, for all eye drops treatment groups, open ranibizumab was administered as required."
1,We excluded patients who were taking vitamin D or calcium supplements .
1,We excluded patients who were taking vitamin D or calcium supplements.
1,We excluded patients who were taking vitamin D or calcium supplements.
1,We excluded patients who were taking vitamin D or calcium supplements.
1,We excluded patients who were taking vitamin D or calcium supplements.
4,These individual barriers might be addressed though patient navigation interventions .
4,These individual barriers could be overcome by patient navigation interventions.
4,These individual barriers could be overcome by patient navigation interventions.
4,These individual barriers could be overcome by patient navigation interventions.
4,These individual barriers could be overcome by patient navigation interventions.
3,We suggest that one definitive local treatment modality combined with neoadjuvant chemotherapy is adequate to treat resectable stage IIIA/N2 non-small-cell lung cancer .
3,We suggest that a definitive local treatment modality combined with neoadjuvant chemotherapy is adequate to treat non-small cell lung cancer of stage IIIA/N2 resectable.
3,We suggest that a definitive local treatment modality combined with neoadjuvant chemotherapy is adequate to treat non-small cell lung cancer of stage IIIA/N2 resectable.
3,We suggest that a definitive local treatment modality combined with neoadjuvant chemotherapy is adequate to treat non-small cell lung cancer of stage IIIA/N2 resectable.
3,We suggest that a definitive local treatment modality combined with neoadjuvant chemotherapy is adequate to treat non-small cell lung cancer of stage IIIA/N2 resectable.
0,The objective of the present study was to determine the pharmacokinetics ( PK ) of a pilsicainide hydrochloride injection in healthy Chinese adults .
0,The objective of this study was to determine the pharmacokinetics ( PK ) of an injection of pilsicainide hydrochloride in healthy Chinese adults.
0,The objective of this study was to determine the pharmacokinetics ( PK ) of an injection of pilsicainide hydrochloride in healthy Chinese adults.
0,The objective of this study was to determine the pharmacokinetics ( PK ) of an injection of pilsicainide hydrochloride in healthy Chinese adults.
0,The objective of this study was to determine the pharmacokinetics ( PK ) of an injection of pilsicainide hydrochloride in healthy Chinese adults.
3,"In this population , BRCA-1 methylation was associated with a significant decrease in DFS events suggesting a better prognosis and potentially retained activity of DNA-damaging agents ."
3,"In this population, BRCA-1 methylation was associated with a significant decrease in DFS events suggesting a better prognosis and potentially retained activity of DNA degradation agents."
3,"In this population, BRCA-1 methylation was associated with a significant decrease in DFS events suggesting a better prognosis and potentially retained activity of DNA degradation agents."
3,"In this population, BRCA-1 methylation was associated with a significant decrease in DFS events suggesting a better prognosis and potentially retained activity of DNA degradation agents."
3,"In this population, BRCA-1 methylation was associated with a significant decrease in DFS events suggesting a better prognosis and potentially retained activity of DNA degradation agents."
4,Pregabalin may be an effective alternative .
4,Pregabalin can be an effective alternative.
4,Pregabalin can be an effective alternative.
4,Pregabalin can be an effective alternative.
4,Pregabalin can be an effective alternative.
2,There were large discrepancies in the number of silicosis cases found .
2,There were large differences in the number of cases of silicosis detected.
2,There were large differences in the number of cases of silicosis detected.
2,There were large differences in the number of cases of silicosis detected.
2,There were large differences in the number of cases of silicosis detected.
1,Patients in the trial group received clean liquid integral protein diet for 3 days before operation without mechanical bowel preparation .
1,"Patients in the study group received a clean, integrated liquid protein regimen for 3 days prior to surgery without mechanical intestinal preparation."
1,"Patients in the study group received a clean, integrated liquid protein regimen for 3 days prior to surgery without mechanical intestinal preparation."
1,"Patients in the study group received a clean, integrated liquid protein regimen for 3 days prior to surgery without mechanical intestinal preparation."
1,"Patients in the study group received a clean, integrated liquid protein regimen for 3 days prior to surgery without mechanical intestinal preparation."
0,The purpose of this study was to determine whether 24 months of combined denosumab and teriparatide will increase hip and spine BMD more than either individual agent .
0,The objective of this study was to determine whether 24 months of combined denosumab and teriparatide will increase the BMD of the hip and spine more than any of the individual agents.
0,The objective of this study was to determine whether 24 months of combined denosumab and teriparatide will increase the BMD of the hip and spine more than any of the individual agents.
0,The objective of this study was to determine whether 24 months of combined denosumab and teriparatide will increase the BMD of the hip and spine more than any of the individual agents.
0,The objective of this study was to determine whether 24 months of combined denosumab and teriparatide will increase the BMD of the hip and spine more than any of the individual agents.
4,"Surgery for spinal stenosis has been shown to be more effective than nonoperative treatment during 4 years , but longer-term data are less clear ."
4,"Surgery of spinal stenosis was more effective than non-operative treatment for 4 years, but longer-term data are less clear."
4,"Surgery of spinal stenosis was more effective than non-operative treatment for 4 years, but longer-term data are less clear."
4,"Surgery of spinal stenosis was more effective than non-operative treatment for 4 years, but longer-term data are less clear."
4,"Surgery of spinal stenosis was more effective than non-operative treatment for 4 years, but longer-term data are less clear."
3,These effects do not appear to explain the glucose-lowering effect of rosiglitazone .
3,These effects do not appear to explain the hypoglycaemic effect of rosiglitazone.
3,These effects do not appear to explain the hypoglycaemic effect of rosiglitazone.
3,These effects do not appear to explain the hypoglycaemic effect of rosiglitazone.
3,These effects do not appear to explain the hypoglycaemic effect of rosiglitazone.
1,"An acute resistance exercise protocol was administered at 0 , 6 , and 12 weeks of training ."
1,"An acute resistance exercise protocol was administered at 0, 6 and 12 weeks of training."
1,"An acute resistance exercise protocol was administered at 0, 6 and 12 weeks of training."
1,"An acute resistance exercise protocol was administered at 0, 6 and 12 weeks of training."
1,"An acute resistance exercise protocol was administered at 0, 6 and 12 weeks of training."
4,Register of Clinical Trials of Australia and New Zealand ( ACTRN1261/2001168842 ).
4,Introduction of calcineurin inhibitors had led to improved survival rates in liver transplant recipients .
4,The introduction of calcineurine inhibitors has improved survival rates in liver transplant recipients.
4,The introduction of calcineurine inhibitors has improved survival rates in liver transplant recipients.
4,The introduction of calcineurine inhibitors has improved survival rates in liver transplant recipients.
4,The introduction of calcineurine inhibitors has improved survival rates in liver transplant recipients.
1,PiCCO catheter was placed in modified surviving sepsis bundles group .
1,The PiCCO catheter was placed in a modified group of surviving septic beams.
1,The PiCCO catheter was placed in a modified group of surviving septic beams.
1,The PiCCO catheter was placed in a modified group of surviving septic beams.
1,The PiCCO catheter was placed in a modified group of surviving septic beams.
0,To assess whether vaginal misoprostol or oral nonsteroidal anti-inflammatory drugs ( NSAIDs ) reduce pain during and 30 minutes after hysterosalpingography ( HSG ) .
0,To assess whether vaginal misoprostol or oral nonsteroidal anti-inflammatory drugs (NSAIDs) reduce pain during and 30 minutes after hysterosalpingography (HSG).
0,To assess whether vaginal misoprostol or oral nonsteroidal anti-inflammatory drugs (NSAIDs) reduce pain during and 30 minutes after hysterosalpingography (HSG).
0,To assess whether vaginal misoprostol or oral nonsteroidal anti-inflammatory drugs (NSAIDs) reduce pain during and 30 minutes after hysterosalpingography (HSG).
0,To assess whether vaginal misoprostol or oral nonsteroidal anti-inflammatory drugs (NSAIDs) reduce pain during and 30 minutes after hysterosalpingography (HSG).
1,"After each LC , intervention group subjects received video-based coaching by a surgeon , utilizing an adaptation of the GROW ( Goals , Reality , Options , Wrap-up ) coaching model ."
1,"After each LC, the subjects of the intervention groups received a video coaching by a surgeon, using an adaptation of the GROW coaching model (Objectives, Reality, Options, Wrap-up)."
1,"After each LC, the subjects of the intervention groups received a video coaching by a surgeon, using an adaptation of the GROW coaching model (Objectives, Reality, Options, Wrap-up)."
1,"After each LC, the subjects of the intervention groups received a video coaching by a surgeon, using an adaptation of the GROW coaching model (Objectives, Reality, Options, Wrap-up)."
1,"After each LC, the subjects of the intervention groups received a video coaching by a surgeon, using an adaptation of the GROW coaching model (Objectives, Reality, Options, Wrap-up)."
0,To compare visual acuity with two visual acuity charts in preschool children .
0,To compare visual acuity with two visual acuity graphs in preschool children.
0,To compare visual acuity with two visual acuity graphs in preschool children.
0,To compare visual acuity with two visual acuity graphs in preschool children.
0,To compare visual acuity with two visual acuity graphs in preschool children.
0,To assess the efficacy of trabeculectomy with a biodegradable Ologen implant ( OLO ) versus mitomycin C ( MMC ) in patients in a prospective randomized clinical trial .
0,Evaluate the efficacy of trabeculectomy with a biodegradable Ologen implant (BLO) compared to mitomycin C (MCM) in patients in a prospective randomised clinical study.
0,Evaluate the efficacy of trabeculectomy with a biodegradable Ologen implant (BLO) compared to mitomycin C (MCM) in patients in a prospective randomised clinical study.
0,Evaluate the efficacy of trabeculectomy with a biodegradable Ologen implant (BLO) compared to mitomycin C (MCM) in patients in a prospective randomised clinical study.
0,Evaluate the efficacy of trabeculectomy with a biodegradable Ologen implant (BLO) compared to mitomycin C (MCM) in patients in a prospective randomised clinical study.
1,The primary outcome was complete ulcer healing .
1,The main result was the complete recovery of ulcers.
1,The main result was the complete recovery of ulcers.
1,The main result was the complete recovery of ulcers.
1,The main result was the complete recovery of ulcers.
2,Adverse reactions had nothing to do with CM treatment .
2,Side effects have nothing to do with treatment with CM.
2,Side effects have nothing to do with treatment with CM.
2,Side effects have nothing to do with treatment with CM.
2,Side effects have nothing to do with treatment with CM.
4,Calcium intake during growth is essential for future bone health but varies widely between individuals and populations .
4,"Calcium intake during growth is essential for future bone health, but varies greatly from individual to individual and population to population."
4,"Calcium intake during growth is essential for future bone health, but varies greatly from individual to individual and population to population."
4,"Calcium intake during growth is essential for future bone health, but varies greatly from individual to individual and population to population."
4,"Calcium intake during growth is essential for future bone health, but varies greatly from individual to individual and population to population."
3,"Cinitapride usage is well tolerated , but its cardiovascular events need further evaluation ."
3,"The use of cinitapride is well tolerated, but its cardiovascular events require further evaluation."
3,"The use of cinitapride is well tolerated, but its cardiovascular events require further evaluation."
3,"The use of cinitapride is well tolerated, but its cardiovascular events require further evaluation."
3,"The use of cinitapride is well tolerated, but its cardiovascular events require further evaluation."
0,It is unknown if this association is causal .
0,We don't know if this association is causal.
0,We don't know if this association is causal.
0,We don't know if this association is causal.
0,We don't know if this association is causal.
1,Follow-up in the ACCORD Lipid Trial was 4-8 years ( mean 4.7 years ) .
1,The follow-up in the ACCORD lipid trial was between 4 and 8 years (an average of 4.7 years).
1,The follow-up in the ACCORD lipid trial was between 4 and 8 years (an average of 4.7 years).
1,The follow-up in the ACCORD lipid trial was between 4 and 8 years (an average of 4.7 years).
1,The follow-up in the ACCORD lipid trial was between 4 and 8 years (an average of 4.7 years).
1,"Additionally , PSD was applied once per week during the treatment ."
1,"In addition, DSP was applied once a week during treatment."
1,"In addition, DSP was applied once a week during treatment."
1,"In addition, DSP was applied once a week during treatment."
1,"In addition, DSP was applied once a week during treatment."
4,"UMIN000014559 , UMIN Clinical Trials Registry , registered on 15 July 2014 ."
4,"UMIN000014559, UMIN Clinical Trials Registry, registered July 15, 2014."
4,"UMIN000014559, UMIN Clinical Trials Registry, registered July 15, 2014."
4,"UMIN000014559, UMIN Clinical Trials Registry, registered July 15, 2014."
4,"UMIN000014559, UMIN Clinical Trials Registry, registered July 15, 2014."
4,Date 22nd July 2011 .
4,Date 22 July 2011.
4,Date 22 July 2011.
4,Date 22 July 2011.
4,Date 22 July 2011.
4,Several studies indicate that increasing the alimentary limb length in gastric bypass surgery produces only a minor improvement of excess BMI loss .
4,Several studies indicate that increasing the length of food members in gastric bypass surgery produces only a slight improvement in the excess loss of BMI.
4,Several studies indicate that increasing the length of food members in gastric bypass surgery produces only a slight improvement in the excess loss of BMI.
4,Several studies indicate that increasing the length of food members in gastric bypass surgery produces only a slight improvement in the excess loss of BMI.
4,Several studies indicate that increasing the length of food members in gastric bypass surgery produces only a slight improvement in the excess loss of BMI.
2,The HRQOL evaluation showed no statistical difference between groups with and without CNI at any interval .
2,The HRQOL evaluation showed no statistical differences between groups with and without NCI at any interval.
2,The HRQOL evaluation showed no statistical differences between groups with and without NCI at any interval.
2,The HRQOL evaluation showed no statistical differences between groups with and without NCI at any interval.
2,The HRQOL evaluation showed no statistical differences between groups with and without NCI at any interval.
2,The mean LOS for the standard practice cohort was 5.3 4.6 days versus calculated LOS using the PCT guidance pathway of 3.7 2.8 days .
2,The average LOS for the standard practice cohort was 5.3 4.6 days compared to the LOS calculated using the PCT orientation route of 3.7 2.8 days.
2,The average LOS for the standard practice cohort was 5.3 4.6 days compared to the LOS calculated using the PCT orientation route of 3.7 2.8 days.
2,The average LOS for the standard practice cohort was 5.3 4.6 days compared to the LOS calculated using the PCT orientation route of 3.7 2.8 days.
2,The average LOS for the standard practice cohort was 5.3 4.6 days compared to the LOS calculated using the PCT orientation route of 3.7 2.8 days.
0,The aims of the present study were to assess the efficacy and safety of BT injection and combined treatment with BT injection and lowered dose glyceryltrinitrate ( GTN ) cream for the treatment of CAF .
0,The objectives of this study were to assess the efficacy and safety of BT injection and treatment combined with BT injection and reduction of the dose of glyceryltrinitrate cream (GTN ) for the treatment of CAF.
0,The objectives of this study were to assess the efficacy and safety of BT injection and treatment combined with BT injection and reduction of the dose of glyceryltrinitrate cream (GTN ) for the treatment of CAF.
0,The objectives of this study were to assess the efficacy and safety of BT injection and treatment combined with BT injection and reduction of the dose of glyceryltrinitrate cream (GTN ) for the treatment of CAF.
0,The objectives of this study were to assess the efficacy and safety of BT injection and treatment combined with BT injection and reduction of the dose of glyceryltrinitrate cream (GTN ) for the treatment of CAF.
4,The aim of the present study was to evaluate the long-term effect of MBP regarding cancer recurrence and survival after colonic resections .
4,The objective of this study was to assess the long-term effect of BPM on the recurrence and survival of cancer after colon resections.
4,The objective of this study was to assess the long-term effect of BPM on the recurrence and survival of cancer after colon resections.
4,The objective of this study was to assess the long-term effect of BPM on the recurrence and survival of cancer after colon resections.
4,The objective of this study was to assess the long-term effect of BPM on the recurrence and survival of cancer after colon resections.
4,Knowledge among critical care nurses and their adherence to evidence-based guidelines for preventing ventilator-associated pneumonia is reported to be low .
4,Nurses' knowledge of essential care and compliance with evidence-based guidelines to prevent ventilator-associated pneumonia would be weak.
4,Nurses' knowledge of essential care and compliance with evidence-based guidelines to prevent ventilator-associated pneumonia would be weak.
4,Nurses' knowledge of essential care and compliance with evidence-based guidelines to prevent ventilator-associated pneumonia would be weak.
4,Nurses' knowledge of essential care and compliance with evidence-based guidelines to prevent ventilator-associated pneumonia would be weak.
0,The aim of this study is to evaluate whether BMD changes after cessation of ronacaleret treatment .
0,The objective of this study is to assess whether BMD changes after discontinuation of ronicalaret therapy.
0,The objective of this study is to assess whether BMD changes after discontinuation of ronicalaret therapy.
0,The objective of this study is to assess whether BMD changes after discontinuation of ronicalaret therapy.
0,The objective of this study is to assess whether BMD changes after discontinuation of ronicalaret therapy.
3,"The rates of infection , rash , and abnormalities on liver-function testing were higher with daclizumab HYP than with interferon beta-1a ."
3,"Rates of infection, rash and abnormalities in liver function tests were higher with daclizumab HYP than with interferon beta-1a."
3,"Rates of infection, rash and abnormalities in liver function tests were higher with daclizumab HYP than with interferon beta-1a."
3,"Rates of infection, rash and abnormalities in liver function tests were higher with daclizumab HYP than with interferon beta-1a."
3,"Rates of infection, rash and abnormalities in liver function tests were higher with daclizumab HYP than with interferon beta-1a."
0,The treatment of bipolar disorder type I ( BD-I ) with a comorbid cocaine dependence disorder ( CDD ) is a challenge in current psychiatric practice .
0,Treatment of bipolar type I disorder (BD-I) with a co-morbid cocaine addiction disorder (CDD) is a challenge in current psychiatric practice.
0,Treatment of bipolar type I disorder (BD-I) with a co-morbid cocaine addiction disorder (CDD) is a challenge in current psychiatric practice.
0,Treatment of bipolar type I disorder (BD-I) with a co-morbid cocaine addiction disorder (CDD) is a challenge in current psychiatric practice.
0,Treatment of bipolar type I disorder (BD-I) with a co-morbid cocaine addiction disorder (CDD) is a challenge in current psychiatric practice.
1,"Secondary outcomes include time until full sustainable return to work , health related quality of life , health related behavior , functional status , somatic and mental health , and perceptions of work ."
1,"Secondary outcomes include time to a full and sustainable return to work, health-related quality of life, health-related behaviour, functional status, somatic and mental health, and work perceptions."
1,"Secondary outcomes include time to a full and sustainable return to work, health-related quality of life, health-related behaviour, functional status, somatic and mental health, and work perceptions."
1,"Secondary outcomes include time to a full and sustainable return to work, health-related quality of life, health-related behaviour, functional status, somatic and mental health, and work perceptions."
1,"Secondary outcomes include time to a full and sustainable return to work, health-related quality of life, health-related behaviour, functional status, somatic and mental health, and work perceptions."
3,A 12-week RTP improved MVIC and muscle power in MS patients .
3,A 12-week RTP improved MVIC and muscle strength in patients with MS.
3,A 12-week RTP improved MVIC and muscle strength in patients with MS.
3,A 12-week RTP improved MVIC and muscle strength in patients with MS.
3,A 12-week RTP improved MVIC and muscle strength in patients with MS.
4,"To actually change physicians ' practice , a tailored strategy aimed at barriers that hinder physicians in abandoning the use of erythropoietin and perioperative blood salvage was systematically developed ."
4,"To change physician practice, an appropriate strategy to prevent physicians from abandoning the use of erythropoietin and perioperative blood recovery has been systematically developed."
4,"To change physician practice, an appropriate strategy to prevent physicians from abandoning the use of erythropoietin and perioperative blood recovery has been systematically developed."
4,"To change physician practice, an appropriate strategy to prevent physicians from abandoning the use of erythropoietin and perioperative blood recovery has been systematically developed."
4,"To change physician practice, an appropriate strategy to prevent physicians from abandoning the use of erythropoietin and perioperative blood recovery has been systematically developed."
4,"Standard Trauma Focused Cognitive Behavioral Therapy may be insufficient for children traumatized by exposure to interparental violence , given the pervasive impact of interparental violence on the family system ."
4,"Standard cognitive trauma therapy may be insufficient for children traumatized by exposure to interparental violence, given the widespread impact of interparental violence on the family system."
4,"Standard cognitive trauma therapy may be insufficient for children traumatized by exposure to interparental violence, given the widespread impact of interparental violence on the family system."
4,"Standard cognitive trauma therapy may be insufficient for children traumatized by exposure to interparental violence, given the widespread impact of interparental violence on the family system."
4,"Standard cognitive trauma therapy may be insufficient for children traumatized by exposure to interparental violence, given the widespread impact of interparental violence on the family system."
3,"Consistent with the hypothesis that ALS is a multisystem disorder , this deficit is related to disease in prefrontal regions ."
3,"Based on the assumption that ALS is a multisystemic disorder, this deficiency is related to disease in the prefrontal regions."
3,"Based on the assumption that ALS is a multisystemic disorder, this deficiency is related to disease in the prefrontal regions."
3,"Based on the assumption that ALS is a multisystemic disorder, this deficiency is related to disease in the prefrontal regions."
3,"Based on the assumption that ALS is a multisystemic disorder, this deficiency is related to disease in the prefrontal regions."
0,"To assess the relative bioavailability of a new subcutaneous ( SC ) diclofenac hydroxypropyl b-cyclodextrin ( HPbCD ) formulation administered to three body sites : quadriceps , gluteus , and abdomen ."
0,"To evaluate the relative bioavailability of a new subcutaneous formulation ( SC ) of diclofenac hydroxypropyl b-cyclodextrin ( HPbCD ) administered at three sites: quadriceps, gluteus and abdomen."
0,"To evaluate the relative bioavailability of a new subcutaneous formulation ( SC ) of diclofenac hydroxypropyl b-cyclodextrin ( HPbCD ) administered at three sites: quadriceps, gluteus and abdomen."
0,"To evaluate the relative bioavailability of a new subcutaneous formulation ( SC ) of diclofenac hydroxypropyl b-cyclodextrin ( HPbCD ) administered at three sites: quadriceps, gluteus and abdomen."
0,"To evaluate the relative bioavailability of a new subcutaneous formulation ( SC ) of diclofenac hydroxypropyl b-cyclodextrin ( HPbCD ) administered at three sites: quadriceps, gluteus and abdomen."
1,Patients diagnosed with CTS will be recruited from an outpatient neurology clinic and randomly assigned to the intervention group ( mechanical traction ) or the control group ( care as usual ) .
1,Patients diagnosed with CTS will be recruited from an external neurology clinic and randomly assigned to the intervention group (mechanical traction) or control group (care as usual).
1,Patients diagnosed with CTS will be recruited from an external neurology clinic and randomly assigned to the intervention group (mechanical traction) or control group (care as usual).
1,Patients diagnosed with CTS will be recruited from an external neurology clinic and randomly assigned to the intervention group (mechanical traction) or control group (care as usual).
1,Patients diagnosed with CTS will be recruited from an external neurology clinic and randomly assigned to the intervention group (mechanical traction) or control group (care as usual).
3,Slight differences were seen among the reconstruction algorithms .
3,There were slight differences between reconstruction algorithms.
3,There were slight differences between reconstruction algorithms.
3,There were slight differences between reconstruction algorithms.
3,There were slight differences between reconstruction algorithms.
3,Cerebral oxygenation is significantly improved during BCP surgery when ventilation is adjusted to maintain E ' ( CO ) at 40-42 mm Hg compared with 30-32 mm Hg .
3,Brain oxygenation was significantly improved during BCP surgery when ventilation was adjusted to maintain E'( CO ) at 40-42 mm Hg compared to 30-32 mm Hg.
3,Brain oxygenation was significantly improved during BCP surgery when ventilation was adjusted to maintain E'( CO ) at 40-42 mm Hg compared to 30-32 mm Hg.
3,Brain oxygenation was significantly improved during BCP surgery when ventilation was adjusted to maintain E'( CO ) at 40-42 mm Hg compared to 30-32 mm Hg.
3,Brain oxygenation was significantly improved during BCP surgery when ventilation was adjusted to maintain E'( CO ) at 40-42 mm Hg compared to 30-32 mm Hg.
0,"To determine whether a point-of-care molecular HIV test increases ART access for hospitalized Malawian infants , we simulated a point-of-care test using rapid HIV RNA polymerase chain reaction ( Rapid PCR ) and compared patient outcomes with an optimized standard care that included assessment with the World Health Organization clinical algorithm for HIV infection plus a DNA PCR with a turnaround time of several weeks ( standard care ) ."
0,"In order to determine whether a molecular, point-of-care HIV test increases access to ART for in-patient Malawian infants, we simulated a point-of-care test using a rapid chain reaction to HIV RNA-polymerase ( Rapid PCR) and compared patient results with an optimized standard treatment that included an assessment with the World Health Organization clinical algorithm for HIV infection and a DNA PCR with a multi-week delivery time (standard care)."
0,"In order to determine whether a molecular, point-of-care HIV test increases access to ART for in-patient Malawian infants, we simulated a point-of-care test using a rapid chain reaction to HIV RNA-polymerase ( Rapid PCR) and compared patient results with an optimized standard treatment that included an assessment with the World Health Organization clinical algorithm for HIV infection and a DNA PCR with a multi-week delivery time (standard care)."
0,"In order to determine whether a molecular, point-of-care HIV test increases access to ART for in-patient Malawian infants, we simulated a point-of-care test using a rapid chain reaction to HIV RNA-polymerase ( Rapid PCR) and compared patient results with an optimized standard treatment that included an assessment with the World Health Organization clinical algorithm for HIV infection and a DNA PCR with a multi-week delivery time (standard care)."
0,"In order to determine whether a molecular, point-of-care HIV test increases access to ART for in-patient Malawian infants, we simulated a point-of-care test using a rapid chain reaction to HIV RNA-polymerase ( Rapid PCR) and compared patient results with an optimized standard treatment that included an assessment with the World Health Organization clinical algorithm for HIV infection and a DNA PCR with a multi-week delivery time (standard care)."
4,"The primary objective of this study was to assess the effect of teduglutide on gastric emptying of liquids in healthy subjects , as measured by the pharmacokinetics of acetaminophen ."
4,"The primary objective of this study was to assess the effect of teduglutide on gastric fluid emptying in healthy subjects, as measured by the pharmacokinetics of acetaminophen."
4,"The primary objective of this study was to assess the effect of teduglutide on gastric fluid emptying in healthy subjects, as measured by the pharmacokinetics of acetaminophen."
4,"The primary objective of this study was to assess the effect of teduglutide on gastric fluid emptying in healthy subjects, as measured by the pharmacokinetics of acetaminophen."
4,"The primary objective of this study was to assess the effect of teduglutide on gastric fluid emptying in healthy subjects, as measured by the pharmacokinetics of acetaminophen."
3,High SOC scores were good predictors of successful lifestyle change in subjects at risk of type 2 diabetes .
3,High SOC scores were good predictors of a successful lifestyle change in people at risk for type 2 diabetes.
3,High SOC scores were good predictors of a successful lifestyle change in people at risk for type 2 diabetes.
3,High SOC scores were good predictors of a successful lifestyle change in people at risk for type 2 diabetes.
3,High SOC scores were good predictors of a successful lifestyle change in people at risk for type 2 diabetes.
0,We evaluated ego-integrity and rumination as mediators and assessed whether the effects of the intervention did not differ across middle-aged and older adults .
0,We assessed ego integrity and rumination as mediators and assessed whether the effects of the intervention did not differ between middle-aged adults and older adults.
0,We assessed ego integrity and rumination as mediators and assessed whether the effects of the intervention did not differ between middle-aged adults and older adults.
0,We assessed ego integrity and rumination as mediators and assessed whether the effects of the intervention did not differ between middle-aged adults and older adults.
0,We assessed ego integrity and rumination as mediators and assessed whether the effects of the intervention did not differ between middle-aged adults and older adults.
0,The existing research findings regarding the effects of lemongrass ( Cymbopogon citratus ) tea on renal function indices are conflicting and inconclusive .
0,Existing research findings regarding the effects of limongrass tea ( Cymbopogon citratus ) on indices of renal function are contradictory and inconclusive.
0,Existing research findings regarding the effects of limongrass tea ( Cymbopogon citratus ) on indices of renal function are contradictory and inconclusive.
0,Existing research findings regarding the effects of limongrass tea ( Cymbopogon citratus ) on indices of renal function are contradictory and inconclusive.
0,Existing research findings regarding the effects of limongrass tea ( Cymbopogon citratus ) on indices of renal function are contradictory and inconclusive.
3,Further studies are necessary to determine the appropriate flow rate and indications for NHF in obese patients .
3,Further studies are needed to determine the appropriate flow rate and indications for NHF in obese patients.
3,Further studies are needed to determine the appropriate flow rate and indications for NHF in obese patients.
3,Further studies are needed to determine the appropriate flow rate and indications for NHF in obese patients.
3,Further studies are needed to determine the appropriate flow rate and indications for NHF in obese patients.
0,The present study aimed to compare the postoperative contrast sensitivity functions between wavefront-guided LASIK eyes and their contralateral wavefront-guided PRK eyes .
0,The purpose of this study was to compare the postoperative contrast sensitivity functions between the wave-guided LASIK eyes and their counterlateral wave-oriented PRK eyes.
0,The purpose of this study was to compare the postoperative contrast sensitivity functions between the wave-guided LASIK eyes and their counterlateral wave-oriented PRK eyes.
0,The purpose of this study was to compare the postoperative contrast sensitivity functions between the wave-guided LASIK eyes and their counterlateral wave-oriented PRK eyes.
0,The purpose of this study was to compare the postoperative contrast sensitivity functions between the wave-guided LASIK eyes and their counterlateral wave-oriented PRK eyes.
0,The aim of this study was to determine the efficacy of electrical stimulation when added to conventional physical therapy with regard to clinical and neurophysiologic changes in patients with Bell palsy .
0,The objective of this study was to determine the effectiveness of electrical stimulation when added to conventional physiotherapy with respect to clinical and neurophysiological changes in patients with Bell's paralysis.
0,The objective of this study was to determine the effectiveness of electrical stimulation when added to conventional physiotherapy with respect to clinical and neurophysiological changes in patients with Bell's paralysis.
0,The objective of this study was to determine the effectiveness of electrical stimulation when added to conventional physiotherapy with respect to clinical and neurophysiological changes in patients with Bell's paralysis.
0,The objective of this study was to determine the effectiveness of electrical stimulation when added to conventional physiotherapy with respect to clinical and neurophysiological changes in patients with Bell's paralysis.
0,"We aimed to examine associations of quantitative gastrointestinal and psychological traits with obesity , and to validate the ability of these traits to predict responses of obese individuals to pharmacotherapy ."
0,"We examined associations of quantitative gastrointestinal and psychological traits with obesity, and validated the ability of these traits to predict the responses of obese people to pharmacotherapy."
0,"We examined associations of quantitative gastrointestinal and psychological traits with obesity, and validated the ability of these traits to predict the responses of obese people to pharmacotherapy."
0,"We examined associations of quantitative gastrointestinal and psychological traits with obesity, and validated the ability of these traits to predict the responses of obese people to pharmacotherapy."
0,"We examined associations of quantitative gastrointestinal and psychological traits with obesity, and validated the ability of these traits to predict the responses of obese people to pharmacotherapy."
0,There is ongoing controversy regarding a ` J-curve ' phenomenon such that low and high blood pressure ( BP ) levels are associated with increased risks of recurrent stroke .
0,"There is a continuing controversy about a "" J curvature "" phenomenon so that low and high blood pressure (LP) levels are associated with increased risk of recurrent stroke."
0,"There is a continuing controversy about a "" J curvature "" phenomenon so that low and high blood pressure (LP) levels are associated with increased risk of recurrent stroke."
0,"There is a continuing controversy about a "" J curvature "" phenomenon so that low and high blood pressure (LP) levels are associated with increased risk of recurrent stroke."
0,"There is a continuing controversy about a "" J curvature "" phenomenon so that low and high blood pressure (LP) levels are associated with increased risk of recurrent stroke."
3,"PUFA requirements of children with SAM are not met by current formulations of RUTF , or by an RUTF with elevated short-chain n-3 PUFA without additional preformed long-chain n-3 PUFA ."
3,"PUFA requirements for children with AMS are not met by current RUTF formulations, or by a RUTF with high short chain n-3 PUFA without the additional long chain n-3 PUFA."
3,"PUFA requirements for children with AMS are not met by current RUTF formulations, or by a RUTF with high short chain n-3 PUFA without the additional long chain n-3 PUFA."
3,"PUFA requirements for children with AMS are not met by current RUTF formulations, or by a RUTF with high short chain n-3 PUFA without the additional long chain n-3 PUFA."
3,"PUFA requirements for children with AMS are not met by current RUTF formulations, or by a RUTF with high short chain n-3 PUFA without the additional long chain n-3 PUFA."
3,The use of the heating device upon administration of short-acting insulin analogues in pump-treated type 1 diabetic patients was found to enhance insulin absorption .
3,The use of the heater in the administration of short-acting insulin analogues in pump-treated type 1 diabetic patients has improved insulin absorption.
3,The use of the heater in the administration of short-acting insulin analogues in pump-treated type 1 diabetic patients has improved insulin absorption.
3,The use of the heater in the administration of short-acting insulin analogues in pump-treated type 1 diabetic patients has improved insulin absorption.
3,The use of the heater in the administration of short-acting insulin analogues in pump-treated type 1 diabetic patients has improved insulin absorption.
1,123 older adults with chronic and primary insomnia .
1,123 elderly people with chronic and primary insomnia.
1,123 elderly people with chronic and primary insomnia.
1,123 elderly people with chronic and primary insomnia.
1,123 elderly people with chronic and primary insomnia.
2,"Furthermore , this main effect was not particularly pronounced when the game was played online ."
2,"In addition, this main effect was not particularly pronounced when the game was played online."
2,"In addition, this main effect was not particularly pronounced when the game was played online."
2,"In addition, this main effect was not particularly pronounced when the game was played online."
2,"In addition, this main effect was not particularly pronounced when the game was played online."
0,To compare the clinical benefit of a periodontal dressing applied after a one-stage full-mouth disinfection ( OSFMD ) in patients with chronic periodontitis up to 3months after therapy .
0,Compare the clinical benefit of a periodontal dressing applied after full-mouth disinfection in a single stage (OSFMD) in patients with chronic periodontitis up to 3 months after treatment.
0,Compare the clinical benefit of a periodontal dressing applied after full-mouth disinfection in a single stage (OSFMD) in patients with chronic periodontitis up to 3 months after treatment.
0,Compare the clinical benefit of a periodontal dressing applied after full-mouth disinfection in a single stage (OSFMD) in patients with chronic periodontitis up to 3 months after treatment.
0,Compare the clinical benefit of a periodontal dressing applied after full-mouth disinfection in a single stage (OSFMD) in patients with chronic periodontitis up to 3 months after treatment.
3,In another study a new concept allowing a rapid pathology review before randomization of patients has now been successfully tested and it may well have potential to form the basis for modern networking consultation pathology .
3,"In another study, a new concept allowing a rapid review of pathology prior to randomization of patients has now been successfully tested and it may well have the potential to form the basis of modern networked consultation pathology."
3,"In another study, a new concept allowing a rapid review of pathology prior to randomization of patients has now been successfully tested and it may well have the potential to form the basis of modern networked consultation pathology."
3,"In another study, a new concept allowing a rapid review of pathology prior to randomization of patients has now been successfully tested and it may well have the potential to form the basis of modern networked consultation pathology."
3,"In another study, a new concept allowing a rapid review of pathology prior to randomization of patients has now been successfully tested and it may well have the potential to form the basis of modern networked consultation pathology."
4,There are currently no agreed strategies for vitamin D replenishment after hip fracture surgery .
4,There is currently no agreed strategy for the reconstitution of vitamin D after hip fracture surgery.
4,There is currently no agreed strategy for the reconstitution of vitamin D after hip fracture surgery.
4,There is currently no agreed strategy for the reconstitution of vitamin D after hip fracture surgery.
4,There is currently no agreed strategy for the reconstitution of vitamin D after hip fracture surgery.
